A human embryonic lung fibroblast with a high density of muscarinic acetylcholine receptors
Article first published online: 3 MAR 2005
DOI: 10.1111/j.1432-1033.1988.tb13804.x
Additional Information
How to Cite
ANDRÉ, C., MARULLO, S., CONVENTS, A., LÜ, B. Z., GUILLET, J. G., HOEBEKE, J. and STROSBERG, A. D. (1988), A human embryonic lung fibroblast with a high density of muscarinic acetylcholine receptors. European Journal of Biochemistry, 171: 401–407. doi: 10.1111/j.1432-1033.1988.tb13804.x
Publication History
- Issue published online: 3 MAR 2005
- Article first published online: 3 MAR 2005
- (Received August S/September 30, 1987) – EJB 87 0908
- Abstract
- Article
- References
- Cited By
Binding studies with the radiolabeled muscarinic antagonists dexetimide, quinuclidinyl benzilate and N-methylscopolamine showed that the human embryonic lung fibroblast CCL137 possesses approximately 2 × 105 muscarinic receptors/cell, i.e. 2.1 pmol/mg membrane protein. These receptors showed a marked stereoselectivity towards dexetimide and levetimide and only low affinity for another antagonist, pirenzepine. The muscarinic agonist carbamylcholine inhibited forskolin-stimulated adenylate cyclase and induced phosphatidylinositide turnover in the intact cells. Both effects were inhibited by the muscarinic antagonist atropine. Affinity labeling with tritiated propylbenzylcholine mustard revealed a protein of 72 kDa. Finally, down-regulation of the membrane receptors following prolonged treatment with the agonist carbamylcholine was assessed by means of the hydrophilic antagonist N-methylscopolamine.

1742-4658/asset/olbannerleft.gif?v=1&s=9011db155cccc04ee73e143039b3ec555aa8d349)
1742-4658/asset/olbannerright.gif?v=1&s=8ef64c2fc7142c262292a103cebc627d9bc4459b)
1742-4658/asset/cover.gif?v=1&s=fc98a9fc84ccc5e1b83463cabb40f397544364eb)